Collaborations

Drug discovery deal to focus on ion channel targets

Published in Gene Therapy Weekly, March 25th, 2004

Bionomics Limited announced that it had signed a letter of intent with the Walter and Eliza Hall Institute (WEHI) to establish a drug discovery collaboration in the field of ion channels.

The drug discovery collaboration is focused on Bionomics' proprietary ion channel targets and animal models, which form the basis of Bionomics' R&D Start Grant-funded drug discovery program. The focus of the drug discovery collaboration will be to identify new lead molecules for the treatment of central nervous system (CNS) disorders including epilepsy and anxiety.

"We are pleased to be partnering with WEHI and look forward to working with WEHI's compound library...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2004-03-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry